Lancet Respiratory Medicine, The, ISSN 2213-2600, 2016, Volume 4, Issue 9, pp. 708 - 719
Summary Background 12 months of oral cyclophosphamide has been shown to alter the progression of scleroderma-related interstitial lung disease when compared...
Pulmonary/Respiratory | SURVIVAL | PLACEBO | RESPIRATORY SYSTEM | DYSPNEA | OUTCOMES | SYSTEMIC-SCLEROSIS | CRITICAL CARE MEDICINE | Lung Diseases, Interstitial - etiology | Cyclophosphamide - administration & dosage | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Lung - physiopathology | Lung Diseases, Interstitial - drug therapy | Disease Progression | Scleroderma, Systemic - complications | Scleroderma, Systemic - physiopathology | Adult | Female | Aged | Lung Diseases, Interstitial - physiopathology | Respiratory Function Tests | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage
Pulmonary/Respiratory | SURVIVAL | PLACEBO | RESPIRATORY SYSTEM | DYSPNEA | OUTCOMES | SYSTEMIC-SCLEROSIS | CRITICAL CARE MEDICINE | Lung Diseases, Interstitial - etiology | Cyclophosphamide - administration & dosage | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Lung - physiopathology | Lung Diseases, Interstitial - drug therapy | Disease Progression | Scleroderma, Systemic - complications | Scleroderma, Systemic - physiopathology | Adult | Female | Aged | Lung Diseases, Interstitial - physiopathology | Respiratory Function Tests | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage
Journal Article
Chest, ISSN 0012-3692, 2014, Volume 145, Issue 6, pp. 1186 - 1188
Journal Article
Chest, ISSN 0012-3692, 2015, Volume 148, Issue 4, pp. 944A - 944B
Journal Article
Medical Clinics of North America, ISSN 0025-7125, 07/2012, Volume 96, Issue 4, pp. 849 - 867
Although there are nonmodifiable genetic risk factors for chronic obstructive pulmonary disease (COPD), most known risk factors for development and progression...
Smoking cessation | Air pollution | Environmental hygiene | Occupational exposure | COPD | HOSPITAL ADMISSIONS | PASSIVE SMOKING | LONG-TERM EXPOSURE | LUNG-FUNCTION | RECEPTOR PARTIAL AGONIST | MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | TOBACCO-SMOKE | PARTICULATE AIR-POLLUTION | SUSTAINED-RELEASE BUPROPION | RESPIRATORY SYMPTOMS | Smoking - adverse effects | Marijuana Smoking - adverse effects | Air Pollution - prevention & control | Occupational Exposure - adverse effects | Smoke - adverse effects | Humans | Risk Factors | Air Pollution - adverse effects | Smoke - prevention & control | Pulmonary Disease, Chronic Obstructive - etiology | Smoking Cessation - methods | Marijuana Smoking - prevention & control | Tobacco Smoke Pollution - adverse effects | Pulmonary Disease, Chronic Obstructive - prevention & control | Occupational Exposure - prevention & control | Air Pollutants - adverse effects | Hygiene | Tobacco Smoke Pollution - prevention & control
Smoking cessation | Air pollution | Environmental hygiene | Occupational exposure | COPD | HOSPITAL ADMISSIONS | PASSIVE SMOKING | LONG-TERM EXPOSURE | LUNG-FUNCTION | RECEPTOR PARTIAL AGONIST | MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | TOBACCO-SMOKE | PARTICULATE AIR-POLLUTION | SUSTAINED-RELEASE BUPROPION | RESPIRATORY SYMPTOMS | Smoking - adverse effects | Marijuana Smoking - adverse effects | Air Pollution - prevention & control | Occupational Exposure - adverse effects | Smoke - adverse effects | Humans | Risk Factors | Air Pollution - adverse effects | Smoke - prevention & control | Pulmonary Disease, Chronic Obstructive - etiology | Smoking Cessation - methods | Marijuana Smoking - prevention & control | Tobacco Smoke Pollution - adverse effects | Pulmonary Disease, Chronic Obstructive - prevention & control | Occupational Exposure - prevention & control | Air Pollutants - adverse effects | Hygiene | Tobacco Smoke Pollution - prevention & control
Journal Article
Circulation, ISSN 0009-7322, 05/2006, Volume 113, Issue 21, pp. 2509 - 2515
Background - Vasoreactivity tests are fundamental in evaluating pulmonary arterial hypertension (PAH). Mutations of the transforming growth factor-beta type II...
Genetics | Pulmonary arterial hypertension | Molecular biology | Vasodilation | Vasoconstriction | molecular biology | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | vasodilation | RECEPTOR | CALCIUM-CHANNEL BLOCKERS | INHALED NITRIC-OXIDE | AGENT | genetics | THERAPY | GENE | GERMLINE MUTATIONS | PERIPHERAL VASCULAR DISEASE | vasoconstriction | pulmonary arterial hypertension | Vasoconstriction - genetics | Vasodilator Agents - pharmacology | Bone Morphogenetic Protein Receptors, Type II - genetics | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Hypertension, Pulmonary - genetics | Male | Sequence Analysis, DNA | Vasodilation - genetics | DNA Mutational Analysis | Adolescent | Adult | Female | Mutation
Genetics | Pulmonary arterial hypertension | Molecular biology | Vasodilation | Vasoconstriction | molecular biology | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | vasodilation | RECEPTOR | CALCIUM-CHANNEL BLOCKERS | INHALED NITRIC-OXIDE | AGENT | genetics | THERAPY | GENE | GERMLINE MUTATIONS | PERIPHERAL VASCULAR DISEASE | vasoconstriction | pulmonary arterial hypertension | Vasoconstriction - genetics | Vasodilator Agents - pharmacology | Bone Morphogenetic Protein Receptors, Type II - genetics | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Hypertension, Pulmonary - genetics | Male | Sequence Analysis, DNA | Vasodilation - genetics | DNA Mutational Analysis | Adolescent | Adult | Female | Mutation
Journal Article
PLoS Genetics, ISSN 1553-7390, 07/2008, Volume 4, Issue 7, pp. e1000125 - e1000125
People who begin daily smoking at an early age are at greater risk of long-term nicotine addiction. We tested the hypothesis that associations between...
SMOKING-CESSATION | CIGARETTE-SMOKING | ADULT RATS | CONDITIONED PLACE PREFERENCE | GENETICS & HEREDITY | FAGERSTROM TOLERANCE QUESTIONNAIRE | LUNG-CANCER MORTALITY | SUSCEPTIBILITY LOCUS | POPULATION-SAMPLE | GENOME-WIDE ASSOCIATION | RECEPTOR GENES | Haplotypes | Tobacco Use Disorder - ethnology | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Age Factors | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Smoking - genetics | Nerve Tissue Proteins - genetics | Adolescent | Adult | Female | Tobacco Use Disorder - genetics | Polymorphism, Single Nucleotide | Receptors, Nicotinic - genetics | Cohort Studies | Protein Subunits - genetics | Index Medicus | Studies | Teenagers | Addictions | Smoking | Nicotine
SMOKING-CESSATION | CIGARETTE-SMOKING | ADULT RATS | CONDITIONED PLACE PREFERENCE | GENETICS & HEREDITY | FAGERSTROM TOLERANCE QUESTIONNAIRE | LUNG-CANCER MORTALITY | SUSCEPTIBILITY LOCUS | POPULATION-SAMPLE | GENOME-WIDE ASSOCIATION | RECEPTOR GENES | Haplotypes | Tobacco Use Disorder - ethnology | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Age Factors | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Smoking - genetics | Nerve Tissue Proteins - genetics | Adolescent | Adult | Female | Tobacco Use Disorder - genetics | Polymorphism, Single Nucleotide | Receptors, Nicotinic - genetics | Cohort Studies | Protein Subunits - genetics | Index Medicus | Studies | Teenagers | Addictions | Smoking | Nicotine
Journal Article
Journal of Applied Physiology, ISSN 8750-7587, 04/2004, Volume 96, Issue 4, pp. 1365 - 1370
Previous retrospective studies report a core body temperature cooling rate of 3°C/h during avalanche burial. Hypercapnia occurs during avalanche burial...
Avalanche burial | Avalanche survival | Hypothermia | avalanche survival | LOWERS | SPORT SCIENCES | PHYSIOLOGY | hypothermia | RESPIRATION | ARTIFICIAL AIR POCKET | VICTIMS | COLD | HYPOXIA | avalanche burial | CARBON-DIOXIDE | Hypercapnia - physiopathology | Snow | Humans | Male | Mountaineering | Body Temperature | Carbon Dioxide | Regression Analysis | Rectum - physiopathology | Disasters | Time Factors | Adult | Female | Respiration
Avalanche burial | Avalanche survival | Hypothermia | avalanche survival | LOWERS | SPORT SCIENCES | PHYSIOLOGY | hypothermia | RESPIRATION | ARTIFICIAL AIR POCKET | VICTIMS | COLD | HYPOXIA | avalanche burial | CARBON-DIOXIDE | Hypercapnia - physiopathology | Snow | Humans | Male | Mountaineering | Body Temperature | Carbon Dioxide | Regression Analysis | Rectum - physiopathology | Disasters | Time Factors | Adult | Female | Respiration
Journal Article
8.
Full Text
Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development
Science Translational Medicine, ISSN 1946-6234, 04/2010, Volume 2, Issue 26, pp. 26ra25 - ra25
Although only a subset of smokers develop lung cancer, we cannot determine which smokers are at highest risk for cancer development, nor do we know the...
BRONCHIAL EPITHELIUM | TRANSFORMATION | MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN-KINASE-C | EPITHELIAL GENE-EXPRESSION | SIGNATURES | 3-KINASE | SMOKERS | MUTATIONS | MYOINOSITOL | CELL-LINES | CELL BIOLOGY | Bronchi - enzymology | Epithelial Cells - drug effects | Humans | Middle Aged | Lung Neoplasms - pathology | Phosphatidylinositol 3-Kinases - metabolism | Pulmonary Disease, Chronic Obstructive - pathology | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Bronchi - drug effects | Adult | Precancerous Conditions - pathology | Gene Expression Regulation, Neoplastic - drug effects | Bronchi - pathology | Lung Neoplasms - genetics | Inositol - pharmacology | Precancerous Conditions - enzymology | Reproducibility of Results | Lung Neoplasms - enzymology | Enzyme Inhibitors - pharmacology | PTEN Phosphohydrolase - metabolism | Epithelial Cells - pathology | Enzyme Activation - drug effects | Pulmonary Disease, Chronic Obstructive - enzymology | Smoking - metabolism | Epithelial Cells - enzymology | Smoking - pathology | Aged | Cohort Studies
BRONCHIAL EPITHELIUM | TRANSFORMATION | MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN-KINASE-C | EPITHELIAL GENE-EXPRESSION | SIGNATURES | 3-KINASE | SMOKERS | MUTATIONS | MYOINOSITOL | CELL-LINES | CELL BIOLOGY | Bronchi - enzymology | Epithelial Cells - drug effects | Humans | Middle Aged | Lung Neoplasms - pathology | Phosphatidylinositol 3-Kinases - metabolism | Pulmonary Disease, Chronic Obstructive - pathology | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Bronchi - drug effects | Adult | Precancerous Conditions - pathology | Gene Expression Regulation, Neoplastic - drug effects | Bronchi - pathology | Lung Neoplasms - genetics | Inositol - pharmacology | Precancerous Conditions - enzymology | Reproducibility of Results | Lung Neoplasms - enzymology | Enzyme Inhibitors - pharmacology | PTEN Phosphohydrolase - metabolism | Epithelial Cells - pathology | Enzyme Activation - drug effects | Pulmonary Disease, Chronic Obstructive - enzymology | Smoking - metabolism | Epithelial Cells - enzymology | Smoking - pathology | Aged | Cohort Studies
Journal Article
Nature Communications, ISSN 2041-1723, 07/2017, Volume 8, Issue 1, p. 16077
Multinucleate cellular syncytial formation is a hallmark of skeletal muscle differentiation. Myomaker, encoded by Mymk (Tmem8c), is a well-conserved plasma...
MUSCLE-FIBER-TYPE | MEGF10 | CRANIAL MUSCLES | MULTIDISCIPLINARY SCIENCES | WEB TOOL | CONGENITAL MYOPATHIES | MUTATIONS | DISPROPORTION | MYOMAKER | GENOME | ROBIN-SEQUENCE | Humans | Infant | Male | Muscle Proteins - deficiency | Muscle, Skeletal - metabolism | Genetic Complementation Test | Cell Fusion | Membrane Proteins - deficiency | Myoblasts - metabolism | Adult | Female | Child | Pierre Robin Syndrome - pathology | Disease Models, Animal | Amino Acid Sequence | Gene Expression | Morphogenesis - genetics | Muscle, Skeletal - growth & development | Membrane Proteins - genetics | Muscular Diseases - metabolism | Mobius Syndrome - pathology | Mobius Syndrome - metabolism | Zebrafish | Muscular Diseases - pathology | Myoblasts - pathology | Genes, Recessive | Mobius Syndrome - genetics | Muscle Proteins - genetics | Pierre Robin Syndrome - metabolism | Sequence Homology, Amino Acid | Sequence Alignment | Zebrafish Proteins - deficiency | Animals | Pierre Robin Syndrome - genetics | Pedigree | Embryo, Nonmammalian | Muscle, Skeletal - pathology | Muscular Diseases - genetics | Mutation | Zebrafish Proteins - genetics | Myotubes | Coding | Disorders | Differentiation | Cell fusion | Fusion protein | In vitro methods and tests | Skeletal muscle | Myopathy | Membrane proteins
MUSCLE-FIBER-TYPE | MEGF10 | CRANIAL MUSCLES | MULTIDISCIPLINARY SCIENCES | WEB TOOL | CONGENITAL MYOPATHIES | MUTATIONS | DISPROPORTION | MYOMAKER | GENOME | ROBIN-SEQUENCE | Humans | Infant | Male | Muscle Proteins - deficiency | Muscle, Skeletal - metabolism | Genetic Complementation Test | Cell Fusion | Membrane Proteins - deficiency | Myoblasts - metabolism | Adult | Female | Child | Pierre Robin Syndrome - pathology | Disease Models, Animal | Amino Acid Sequence | Gene Expression | Morphogenesis - genetics | Muscle, Skeletal - growth & development | Membrane Proteins - genetics | Muscular Diseases - metabolism | Mobius Syndrome - pathology | Mobius Syndrome - metabolism | Zebrafish | Muscular Diseases - pathology | Myoblasts - pathology | Genes, Recessive | Mobius Syndrome - genetics | Muscle Proteins - genetics | Pierre Robin Syndrome - metabolism | Sequence Homology, Amino Acid | Sequence Alignment | Zebrafish Proteins - deficiency | Animals | Pierre Robin Syndrome - genetics | Pedigree | Embryo, Nonmammalian | Muscle, Skeletal - pathology | Muscular Diseases - genetics | Mutation | Zebrafish Proteins - genetics | Myotubes | Coding | Disorders | Differentiation | Cell fusion | Fusion protein | In vitro methods and tests | Skeletal muscle | Myopathy | Membrane proteins
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 01/2014, Volume 12, Issue 1, pp. 9 - 9
Background: As a part of the longitudinal Chronic Obstructive Pulmonary Disease (COPD) study, Subpopulations and Intermediate Outcome Measures in COPD study...
Multiplex assays | Pilot study | Blood analytes | Biomarkers | P100 plasma | Serum | Chronic obstructive pulmonary disease | EDTA plasma | SPIROMICS | COPD | MEDICINE, RESEARCH & EXPERIMENTAL | COLLECTION | ACTIVATION | ANTICOAGULANTS | PROTEOME | BLOOD | Diagnostic Techniques, Respiratory System | Plasma - metabolism | Reproducibility of Results | Edetic Acid - chemistry | Serum - metabolism | Humans | Middle Aged | Protease Inhibitors | Pulmonary Disease, Chronic Obstructive - blood | Female | Male | Biomarkers - blood | Proteins | Medicine | Studies | Plasma | Anticoagulants | Blood platelets | Cytokines | Internal medicine | Pathogenesis
Multiplex assays | Pilot study | Blood analytes | Biomarkers | P100 plasma | Serum | Chronic obstructive pulmonary disease | EDTA plasma | SPIROMICS | COPD | MEDICINE, RESEARCH & EXPERIMENTAL | COLLECTION | ACTIVATION | ANTICOAGULANTS | PROTEOME | BLOOD | Diagnostic Techniques, Respiratory System | Plasma - metabolism | Reproducibility of Results | Edetic Acid - chemistry | Serum - metabolism | Humans | Middle Aged | Protease Inhibitors | Pulmonary Disease, Chronic Obstructive - blood | Female | Male | Biomarkers - blood | Proteins | Medicine | Studies | Plasma | Anticoagulants | Blood platelets | Cytokines | Internal medicine | Pathogenesis
Journal Article
11.
Full Text
Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease
Journal of Molecular Medicine, ISSN 0946-2716, 12/2018, Volume 96, Issue 12, pp. 1375 - 1385
Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide, and long-term oxygen therapy has been shown to reduce mortality in COPD...
Expression quantitative trait loci | Oxygen | Arylsulfatase B | Genome-wide association study | Microarray | Pharmacogenomics | MEDICINE, RESEARCH & EXPERIMENTAL | OXIDATIVE STRESS | GENETIC SUSCEPTIBILITY | EMPHYSEMA | GENETICS & HEREDITY | MITOCHONDRIAL DYSFUNCTION | RETINOPATHY | EXPRESSION | Pharmacogenetics | Lung diseases, Obstructive | Care and treatment | Usage | Oxygen therapy | Genetic aspects | Research | Respiratory therapy | Therapy | Epithelial cells | Genes | Genomics | Lung diseases | Oxygen enrichment | Single-nucleotide polymorphism | Gene expression | Patients | Loci | Blood | Quantitative trait loci | Mitochondria | Hypoxemia | DNA microarrays | Network analysis | Obstructive lung disease | Peripheral blood | Biomarkers | Arylsulfatase | Chronic obstructive pulmonary disease | expression quantitative trait loci | microarray | pharmacogenomics | oxygen | genome-wide association study
Expression quantitative trait loci | Oxygen | Arylsulfatase B | Genome-wide association study | Microarray | Pharmacogenomics | MEDICINE, RESEARCH & EXPERIMENTAL | OXIDATIVE STRESS | GENETIC SUSCEPTIBILITY | EMPHYSEMA | GENETICS & HEREDITY | MITOCHONDRIAL DYSFUNCTION | RETINOPATHY | EXPRESSION | Pharmacogenetics | Lung diseases, Obstructive | Care and treatment | Usage | Oxygen therapy | Genetic aspects | Research | Respiratory therapy | Therapy | Epithelial cells | Genes | Genomics | Lung diseases | Oxygen enrichment | Single-nucleotide polymorphism | Gene expression | Patients | Loci | Blood | Quantitative trait loci | Mitochondria | Hypoxemia | DNA microarrays | Network analysis | Obstructive lung disease | Peripheral blood | Biomarkers | Arylsulfatase | Chronic obstructive pulmonary disease | expression quantitative trait loci | microarray | pharmacogenomics | oxygen | genome-wide association study
Journal Article
Chest, ISSN 0012-3692, 11/2019, Volume 156, Issue 5, pp. 826 - 833
interstitial lung disease | acute lung injury | surgery | OBSTRUCTIVE SLEEP-APNEA | RISK-FACTORS | RESECTION | BIOPSY | NONPULMONARY SURGERY | GENERAL-ANESTHESIA | ABDOMINAL-SURGERY | RESPIRATORY SYSTEM | IDIOPATHIC PULMONARY-FIBROSIS | ACUTE EXACERBATION | RESPIRATORY-FAILURE | CRITICAL CARE MEDICINE
Journal Article
Cough, ISSN 1745-9974, 05/2014, Volume 10, Issue 1, pp. 3 - 3
A polymorphism (rs35705950) in the promoter region of the mucin MUC5B is associated with both familial and sporadic forms of idiopathic pulmonary fibrosis....
Genetic aspects | Pulmonary fibrosis | Analysis | Genetic polymorphisms
Genetic aspects | Pulmonary fibrosis | Analysis | Genetic polymorphisms
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2010, Volume 182, Issue 5, pp. 605 - 613
Rationale: Several family-based studies have identified genetic linkage for lung function and airflow obstruction to chromosome 2q. Objectives: We hypothesized...
Single nucleotide polymorphism | Emphysema | Genetic linkage | Metaanalysis | metaanalysis | PROTEIN | single nucleotide polymorphism | SERPINE2 GENE | genetic linkage | RISK | MECHANISMS | emphysema | RESPIRATORY SYSTEM | EARLY-ONSET | SENESCENCE | LINKAGE | EXPRESSION | COPD | CRITICAL CARE MEDICINE | Smoking - adverse effects | Genetic Predisposition to Disease | Humans | Middle Aged | Male | Chromosome Mapping | Case-Control Studies | Chromosomes, Human, Pair 2 | Amyloid beta-Protein Precursor - genetics | Ku Autoantigen | Age of Onset | Protease Nexins | Female | Aged | Polymorphism, Single Nucleotide | DNA Helicases - genetics | Genetic Linkage | Pulmonary Disease, Chronic Obstructive - genetics | Receptors, Cell Surface - genetics | A. Chronic Obstructive Pulmonary Disease
Single nucleotide polymorphism | Emphysema | Genetic linkage | Metaanalysis | metaanalysis | PROTEIN | single nucleotide polymorphism | SERPINE2 GENE | genetic linkage | RISK | MECHANISMS | emphysema | RESPIRATORY SYSTEM | EARLY-ONSET | SENESCENCE | LINKAGE | EXPRESSION | COPD | CRITICAL CARE MEDICINE | Smoking - adverse effects | Genetic Predisposition to Disease | Humans | Middle Aged | Male | Chromosome Mapping | Case-Control Studies | Chromosomes, Human, Pair 2 | Amyloid beta-Protein Precursor - genetics | Ku Autoantigen | Age of Onset | Protease Nexins | Female | Aged | Polymorphism, Single Nucleotide | DNA Helicases - genetics | Genetic Linkage | Pulmonary Disease, Chronic Obstructive - genetics | Receptors, Cell Surface - genetics | A. Chronic Obstructive Pulmonary Disease
Journal Article
The Lancet Respiratory Medicine, ISSN 2213-2600, 09/2018, Volume 6, Issue 9, pp. 707 - 714
Abnormal acid gastro-oesophageal reflux (GER) is hypothesised to play a role in progression of idiopathic pulmonary fibrosis (IPF). We aimed to determine...
ACID GASTROESOPHAGEAL-REFLUX | ANTACID THERAPY | RESPIRATORY SYSTEM | PIRFENIDONE | MICROASPIRATION | PREVALENCE | DISEASE PROGRESSION | ACUTE EXACERBATION | TRANSPLANTATION | CRITICAL CARE MEDICINE | Care and treatment | Usage | Pulmonary fibrosis | Laparoscopic surgery | Laparoscopy | Diagnosis | Research
ACID GASTROESOPHAGEAL-REFLUX | ANTACID THERAPY | RESPIRATORY SYSTEM | PIRFENIDONE | MICROASPIRATION | PREVALENCE | DISEASE PROGRESSION | ACUTE EXACERBATION | TRANSPLANTATION | CRITICAL CARE MEDICINE | Care and treatment | Usage | Pulmonary fibrosis | Laparoscopic surgery | Laparoscopy | Diagnosis | Research
Journal Article